NCT05369611Completed
COVID-19 Experiences in the SELF Cohort
COVID-19 Experiences in the SELF Cohort: A Cross-Sectional Study
Source: ClinicalTrials.gov · Last updated 3 Nov 2026
Brief summary (registry, in English)
Background: COVID-19 affected African Americans more than Whites. African Americans, especially women, have had higher rates of COVID-19 infections compared to Whites. They are also more likely to go to the hospital or die of this disease. Many researchers who looked into these issues lacked background data on the people they studied. SELF is a 10-year study of fibroids in African American women aged 23-35. Researchers already have a lot of data on these women. Asking how COVID-19 affected them can add context other studies lack. Objective: To describe the impact of the COVID-19 pandemic on young African American women and their families. Eligibility: Participants must be enrolled in SELF (Study of Environment, Lifestyle, and Fibroids). Design: Researchers will invite all women enrolled in SELF to participate in this natural history study. Participants will complete one questionnaire. They will answer the questions online. They may also choose to get a paper copy sent by mail. The survey will take no more than 15-20 minutes. All questions will relate to COVID-19. Participants will be asked if they had COVID-19. They will be asked if family, friends, or members of their community did. They will answer questions about their vaccine status and access to health care services. Participants will also answer questions about how the pandemic affected their lives. They will be asked about their job and if finding childcare was a challenge. They will be asked about money problems and how they coped. They will be asked about sleep problems and emotional distress. Participants will get a $30 gift card after they finish the survey. ...
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 1197 (actual)
- First submitted
- 7 May 2022
- Start date
- 17 Jun 2022
- Primary completion date
- 1 Jan 2024
- Lead sponsor
- National Institute of Environmental Health Sciences (NIEHS)
- NCT number
- NCT05369611
What you commit to
- Study type: Observational
- Participants enrolled: 1197
- From 17 Jun 2022 to the primary completion date, 1 Jan 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- -Not enrolled in the NIEHS the NIEHS s Study of Environment, Lifestyle \& Fibroids (SELF) cohort (i.e. not deceased or previously withdrawn from SELF)
Criteria the registry did not label
- INCLUSION CRITERIA:
- In order to be eligible to participate in this study, an individual must meet all of the following criteria:
- Ongoing enrollment in the NIEHS s Study of Environment, Lifestyle \& Fibroids (SELF) cohort (i.e. not deceased or previously withdrawn from SELF)
- Ability to complete the questionnaire (indicating informed consent)
Age in the registry: 23 years to 35 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| National Institute of Environmental Health Sciences (NIEHS) Coordinator of this site? Confirm its status | Bethesda | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.